A clinical trial of Sathakuppai Chooranam in the management of Kumba vatham(Periarthritis)

A Prospective Open labelled non randomized phase II Clinical trial of Sathakuppai Chooranam in the management of Kumba vatham(Periarthritis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031214

Enrollment

Registered

2021-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Sathakuppai Chooranam: 1g Twice a day Orally after food with Sugar for 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patient having main symptoms of shoulder joint,numbness,wasting in the shoulder region and arms ,restricted movement of upper limbs,loss of abduction&forward flexion,stiffnees of the shoulder joint Diabetes mellitus

Exclusion criteria

Exclusion criteria: Age below 29&above 61 Rheumatoid Arthritis Ischemic heart Disease Hypertension Pregnancy and lactating mother Recent Shoulder dislocation Sub acromial bursitis

Design outcomes

Primary

Measure	Time frame
Reduction of the signs and symptoms of shoulder joint pain Numbness Wasting in the shoulder region and arms restricted movement of the upper limbs loss of abduction loss of forward flexion stiffness of the shoulder jointTimepoint: 45 days	—

Secondary

Measure	Time frame
Evaluation of additional effects and siddha parameters changes in Kumba vathamTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr G Subashchandran MDs PhD

Government Siddha Medical College and Hospital

siddhadrgs21@gmail.com9443358271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026